Sublingual Semaglutide
Semaglutide (the active ingredient in Ozempic® and Wegovy®) works as an agonist on only the GLP-1 (Glucagon-like Peptide-1) receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, and increased feelings of fullness, and it is used to improve blood sugar control and, in higher doses, for weight management.
Flexibility with Dosing
When you use semaglutide sublingually the dose will be daily, so you may find that better for you as far as the way you feel from the effect of the drug. An alternative for the most popular injectable semaglutide.
It’s easy for the patient to use, with no needles.
Offers an alternative for those with needle phobia.
Details
*Activation of the GLP-1 receptor leads to several beneficial effects with both semaglutide and tirzepatide
- Increased insulin release
- Reduced glucagon secretion
- Slowed gastric emptying and increased feelings of fullness
- Decreased hunger through satiety pathways
- Up-modulates fat utilization
- Reduced ghrelin levels in the stomach/gut
High Quality, Fast Turnaround GLP-1 Injections During the FDA Shortage
Compounded Semaglutide & Tirzepatide GLP 1s: How We Help Patients – Patient Video Instructions
